Rani Therapeutics Reports Second Quarter 2026 Financial Results; Provides Corporate Update

Go back to Rani Therapeutics Reports Second Quarter 2026 Financial Results; Provides Corporate Update
(NASDAQ: RANI) Delayed: 0.78 -0.01 (1.27%)
Previous Close $0.79    52 Week High
Open $0.80    52 Week Low
Day High $0.83    P/E N/A 
Day Low $0.78    EPS
Volume 651,978